We further found that miR-328-5p targeted the DAB2IP, one tumor suppressor, because miR-328-5p expression was inversely associated with DAB2IP expression in HCC tissues and cells, and miR-328-5p overexpression mitigated the DAB2IP-regulated luciferase activity. Here, DAB2IP is linked to hepatocellular carcinoma.